Latest Threads on News from companies

NMDC Group PJSC, previously known as National Marine Dredging Company PJSC, has released its report and condensed consolidated interim financial statements for the nine-month period ending on September 30, 2024. These statements are unaudited.

The text highlights the growth in underlying profitability for ADNOC, driven by higher fuel volume and operational expenditure optimization, as reported in their third quarter and nine-month results for 2024.

The Board of Directors of Abu Dhabi National Oil Company for Distribution PJSC (ADNOC Distribution) held a meeting on October 30, 2024, in Abu Dhabi. During the meeting, the Board approved the company's financial statements for the third quarter ending September 30, 2024, and discussed other general business matters. Additionally, ADNOC Distribution announced the formation of a subcommittee under the Executive Committee to support the company's ESG agenda, chaired by Board member Ms. Paula Disberry.

The text pertains to a review report and interim financial information for the nine-month period ending on September 30, 2024, related to ADNOC.

ADNOC Distribution reported record financial results for the first nine months of 2024, with an EBITDA of $790 million and a net profit of $501 million. The company achieved a 9.2% increase in fuel volumes, delivering over 11 billion liters, largely due to network expansion and increased international operations. Non-fuel retail gross profit rose by 13% year-on-year, supported by a 9.4% increase in non-fuel transactions. The company also reported strong free cash flow of $537 million and a net debt-to-EBITDA ratio of 0.56x. Operational efficiency improvements contributed to $13 million in OPEX savings, with a target of $50 million in savings by 2028. CEO Eng. Bader Saeed Al Lamki highlighted the company's solid fundamentals and strong financial performance.

PureHealth reported a net profit of AED 1.4 billion and an EBITDA of AED 3.1 billion for the first nine months of 2024. The company's consolidated revenue increased by 56% to AED 19.0 billion, primarily driven by the Hospitals segment and supported by organic growth and acquisitions. EBITDA rose by 26% compared to the same period in 2023, with an EBITDA margin of 16.5%, indicating operational efficiencies. Net profit increased by 13% year-on-year, with a net profit margin of 7.6%. Key acquisitions included Circle Health Group and Sheikh Shakhbout Medical City, while divestments included YAS Clinics Group and Abu Dhabi Stem Cells Centre. The Hospital Segment saw revenues rise by 87% and EBITDA growth of 18%, while the Insurance Segment recorded a 17% increase in revenue and a 60% growth in EBITDA. Total assets grew by 72% to AED 48.4 billion, with a cash balance of AED 8.7 billion. The net cash position was 3.0x EBITDA, with a net cash balance of AED 6.7 billion. Overall, PureHealth demonstrated strong performance and strategic growth in the first nine months of 2024.